Experienced in Bone Tumor

Dr. Marka R. Crittenden

Radiation Oncology
Providence
4805 Northeast Glisan Street, Garden Level, 
Portland, OR 
Accepting New Patients
Experienced in Bone Tumor
Providence
4805 Northeast Glisan Street, Garden Level, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marka Crittenden is a Radiation Oncologist in Portland, Oregon. Dr. Crittenden is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Cancer, Glioma, and Lung Cancer. Dr. Crittenden is currently accepting new patients.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in OR
Hospital Affiliations
Providence Portland Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

4805 Northeast Glisan Street, Garden Level, Portland, OR 97213
Call: 503-215-6029

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Neoadjuvant Immunoradiotherapy: Head & Neck Cancer (NIRT-HNC)
Neoadjuvant Immunoradiotherapy: Head & Neck Cancer (NIRT-HNC)
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2025
Intervention Type: Procedure, Drug, Radiation
Study Drug: Nivolumab
Study Phase: Phase 1/Phase 2
Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma
Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: March 10, 2025
Intervention Type: Drug, Procedure
Study Drugs: LY2157299, Capecitabine, Fluorouracil
Study Phase: Phase 2
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Renal Cancer
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Renal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 10, 2025
Intervention Type: Radiation, Biological
Study Drug: High Dose IL-2
Study Phase: Phase 2
Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy.
Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy.
Enrollment Status: Completed
Publish Date: March 21, 2019
Intervention Type: Biological
Study Phase: Phase 1
Phase I Study of Safety and Immunogenicity of ADU-623, a Live-attenuated Listeria Monocytogenes Strain (ΔactA/ΔinlB) Expressing the EGFRvIII-NY-ESO-1 Vaccine, in Patients With Treated and Recurrent WHO Grade III/IV Astrocytomas
Phase I Study of Safety and Immunogenicity of ADU-623, a Live-attenuated Listeria Monocytogenes Strain (ΔactA/ΔinlB) Expressing the EGFRvIII-NY-ESO-1 Vaccine, in Patients With Treated and Recurrent WHO Grade III/IV Astrocytomas
Enrollment Status: Completed
Publish Date: August 17, 2018
Intervention Type: Biological, Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

69 Total Publications

A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRI.
A novel structural modeling magnitude and orientation radiomic descriptor for evaluating response to neoadjuvant therapy in rectal cancers via MRI.
Journal: NPJ precision oncology
Published: February 26, 2025
View All 69 Publications
Similar Doctors
Advanced in Bone Tumor
Dr. Arthur Y. Hung
Radiation Oncology
Advanced in Bone Tumor
Dr. Arthur Y. Hung
Radiation Oncology

University Professional Services

3181 Sw Sam Jackson Park Rd, 
Portland, OR 
 (5.0 miles away)
503-494-8311
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arthur Hung is a Radiation Oncologist in Portland, Oregon. Dr. Hung is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Orchiectomy. Dr. Hung is currently accepting new patients.

Experienced in Bone Tumor
Dr. John M. Holland
Radiation Oncology
Experienced in Bone Tumor
Dr. John M. Holland
Radiation Oncology

Portland Adventist Medical Center

10123 Se Market St, 
Portland, OR 
 (2.7 miles away)
503-257-2500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Holland is a Radiation Oncologist in Portland, Oregon. Dr. Holland is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. His top areas of expertise are Laryngeal Cancer, Prostate Cancer, Squamous Cell Skin Carcinoma, and Pleuropulmonary Blastoma. Dr. Holland is currently accepting new patients.

Experienced in Bone Tumor
Dr. Grant A. Harmon
Radiation Oncology
Experienced in Bone Tumor
Dr. Grant A. Harmon
Radiation Oncology

Legacy Clinics LLC

1130 Nw 22nd Ave, Suite 110, 
Portland, OR 
 (4.7 miles away)
503-413-8654
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Grant Harmon is a Radiation Oncologist in Portland, Oregon. Dr. Harmon is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. His top areas of expertise are Prostate Cancer, Cervical Cancer, Familial Prostate Cancer, and Metastatic Brain Tumor. Dr. Harmon is currently accepting new patients.

VIEW MORE BONE TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crittenden's expertise for a condition
ConditionClose
      • Advanced
      • Head and Neck Squamous Cell Carcinoma (HNSCC)
        Dr. Crittenden is
        Advanced
        . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
        See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
      • Experienced
      • Acinic Cell Carcinoma of Salivary Glands
        Dr. Crittenden is
        Experienced
        . Learn about Acinic Cell Carcinoma of Salivary Glands.
        See more Acinic Cell Carcinoma of Salivary Glands experts
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Crittenden is
        Experienced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Anal Cancer
        Dr. Crittenden is
        Experienced
        . Learn about Anal Cancer.
        See more Anal Cancer experts
      • Angiosarcoma
        Dr. Crittenden is
        Experienced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      • Astrocytoma
        Dr. Crittenden is
        Experienced
        . Learn about Astrocytoma.
        See more Astrocytoma experts
      • Bone Tumor
        Dr. Crittenden is
        Experienced
        . Learn about Bone Tumor.
        See more Bone Tumor experts
      View All 32 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.